INTRODUCTION {#sec1}
============

Innate immunity is the first defense line against various pathogens through sensing pathogens, eliminating them, and activating adaptive immune response \[[@B1]\]. In sensing pathogens, nucleic acids (NAs) that are originated from pathogenic bacteria and viruses are recognized by innate immune receptor signaling, which are mediated by pattern recognition receptors (PRRs) including toll-like receptors (TLRs), retinoic acid inducible gene I (RIG-I), melanoma differentiation-associated protein 5 (MDA5), and laboratory of genetics and physiology 2 (LGP2) \[[@B2],[@B3]\]. Among them, TLR3, TLR7/8, TLR9, and TLR13 of TLRs are known as nucleic acid NA-sensing TLRs. They primarily exist in endosome and respond to double-stranded RNA (dsRNA), single-stranded RNA (ssRNA), single-stranded DNA, and bacterial ribosomal RNA respectively \[[@B4],[@B5]\]. RIG-I, MDA5, and LGP2 are cytosolic NA receptors which detect dsRNA. RIG-I primarily responds to 5'-triphosphorylated blunt-ended RNA or dsRNA produced during RNA virus infections and MDA5 responds to long dsRNA \[[@B2]\]. LGP2 also seems to enhance initial MDA5-RNA interaction \[[@B6]\]. Complex with cognate PRRs and their ligands leads to the engagements of myeloid differentiation primary response 88 (MYD88), Toll/IL-1R homologous region (TIR) domain-containing adapter-inducing interferon-*β* (TRIF), or mitochondrial antiviral-signaling protein (MAVS). It activates transcription factors (TFs) such as interferon regulatory factor3 (IRF3), IRF7, nuclear factor kappa B (NF-κB), and activating protein 1 (AP-1) (ATF2/JUN) by orchestrating a combination of multi-protein complexes. The TFs induce to express inflammatory cytokines, chemokines and type I interferons \[[@B7]--[@B12]\].

Among the NA-sensing TLRs, chickens have obvious orthologues of *TLR3* and *TLR7* while *TLR8* has been disrupted by the insertion of a large CR1 repeat \[[@B13]\]. *TLR9* and *TLR13* were also absent \[[@B8],[@B14]\]. In addition, *TLR15* and *TLR21* uniquely existed in chickens compared to human and mouse \[[@B15],[@B16]\]. Chicken *TLR21* has recently been shown to recognize CpG motifs, suggesting a functional homologue to mammalian *TLR9* \[[@B17]\] whereas an virus-related agonist for *TLR15* remains unknown \[[@B18],[@B19]\]. *MDA5* and *LGP2* are also present in chicken genome and their function seems to be similar to mammals whereas *RIG-I* is obviously absent \[[@B20],[@B21]\]. It has been suggested that the lack of *RIG-I* caused a susceptibility for zoonotic RNA virus such as avian influenza in chickens \[[@B22]\]. Even if immune responses to NA have been comparatively well characterized in chickens, the precise mechanism remains to be elucidated.

Polyinosinic:polycytidylic acid (poly\[I:C\]), viral like dsRNA, has generally been used to mimic NA-sensing responses of the innate immune system. Poly(I:C) is recognized by TLR3 and MDA-5, activate various TFs such as IRFs and NF-κB, and stimulates various cytokines and chemokine, IFNs and costimulatory factors in various species \[[@B10],[@B11],[@B23]--[@B26]\]. Poly(I:C) exhibited a toxicity in various tissues and cells \[[@B27],[@B28]\]. Especially, the viability of chicken embryonic fibroblasts (CEFs) reduced to about 80% and below 50% with 1,000 µg/mL of poly(I:C) for 24 h and 72 h respectively and it suggested that poly(I:C) induced apoptosis of CEFs through the activation of caspase-3 and -8 by TNFRSF8 \[[@B29]\]. In addition, DF-1 cells, chicken fibroblast cell line modulated IRF7-related immune signaling pathways responding to poly(I:C) \[[@B30]\]. In this regard, chicken fibroblasts including DF-1 are a useful model to study *in vitro* immune responses which are stimulated by poly(I:C).

In this study, we examined the expression patterns of innate immune signaling-related genes such as canonical and non-canonical TLRs, the related TFs, cytokines, and immune-related effector molecules in chickens after poly(I:C) treatment. Our results could contribute to understanding the gene expression which is involved in NA-sensing and the related responses in chicken cells.

MATERIALS AND METHODS {#sec2}
=====================

Cell culture and poly(I:C) treatment {#sec2-1}
------------------------------------

DF-1 chicken fibroblast cell lines were obtained from the American Type Culture Collection (Rockville, MD, USA) and maintained in the Dulbecco's modified Eagle's medium with 10% fetal bovine serum (Biowest, Nuaillé, France). DF-1 cells were cultured at 37°C in 5% CO~2~ incubator. Poly(I:C) was purchased from Invivogen (San Diego, CA, USA) and was stocked according to the manufacturer's instruction and all poly(I:C) treatment was maintained under the culture condition of DF-1 cells.

Cell viability assay {#sec2-2}
--------------------

Cell viability assays were performed using tetrazolium compound based CellTiter 96^®^ AQueous One Solution Cell Proliferation (MTS) assay (Promega, Madison, WI, USA). MTS assay was then performed according to the manufacturer's instruction at 24 h after treatment at indicated concentrations of poly(I:C).

RNA extraction and quantitative RT-PCR {#sec2-3}
--------------------------------------

RNAs were isolated from DF-1 cells using RNA extraction kit (Invitrogen, CA, USA). For quantitative reverse transcription-polymerase chain reaction (qRT-PCR), 1 µg of total RNA was used for cDNA synthesis with Rever Tra Ace-*α*- first strand cDNA Synthesis Kit (Toyobo, Osaka, Japan). Sequence-specific primers ([Table 1](#T1){ref-type="table"}) were designed using the Primer-BLAST program (<https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHome>). qRT- PCR was performed using the iCycler real-time PCR detection system (Bio-Rad, Hercules, CA, USA) and SYBR Green (Bio-Rad, Hercules, CA, USA). Non-template wells without cDNA were included as negative controls. Each sample was tested in triplicate. The PCR conditions were 95°C for 3 min, followed by 40 cycles at 95°C for 10 s and 60°C for 30 s, using a melting curve program (increasing temperature from 65°C to 95°C at a rate of 0.5°C per 5 s) and continuous fluorescence measurement. The qRT-PCR data were normalized relative to the expression of *GAPDH* and calculated using the 2 ∆∆Ct method, where ∆∆Ct = (Ct of the target gene -- Ct of *GAPDH*) treatment -- (Ct of the target gene -- Ct of *GAPDH*) control \[[@B31]\].

###### Lists of primers used to perform qRT-PCR

  Target gene (accession number of NCBI)   Primer type 5' to 3'   Sequence
  ---------------------------------------- ---------------------- -----------------------------
                                           Reverse                CCTGCTTCGAAGTCTCGTTC
  *TLR4* (417241)                          Forward                TTCCAAGCACCAGATAGCAACATC
                                           Reverse                ACGGGTCACAGAAGAACTTAGGG
  *TLR7* (418638)                          Forward                TTCTGGCCACAGATGTGACC
                                           Reverse                CCTTCAACTTGGCAGTGCAG
  *TLR15* (421219)                         Forward                GTTCTCTCTCCCAGTTTTGTAAATAGC
                                           Reverse                GTGGTTCATTGGTTGTTTTTAGGAC
  *TLR21* (415623)                         Forward                CAACAGACTGCTGGAGGTGA
                                           Reverse                TGCAGCTTCAGGTCGTACAG
  *IRF7* (396330)                          Forward                GAGGATCCGGCCAAATGGAA
                                           Reverse                CCAAATCGTGGTGGTTGAGC
  *JUN* (424673)                           Forward                CCCGGTGTATGCCAATCTCA
                                           Reverse                CTCCTGCGACTCCATGTCAA
  *NF-κB1* (395587)                        Forward                AGAAAAGCTGGGTCTTGGCA
                                           Reverse                CCATCTGTGTCAAAGCAGCG
  *IL1B* (395196)                          Forward                GGATTCTGAGCACACCACAGT
                                           Reverse                TCTGGTTGATGTCGAAGATGTC
  *IL8L2* (396495)                         Forward                CCAAGCACACCTCTCTTCCA
                                           Reverse                GCAAGGTAGGACGCTGGTAA
  *IL10* (428264)                          Forward                AGCAGATCAAGGAGACGTTC
                                           Reverse                ATCAGCAGGTACTCCTCGAT
  *GAPDH* (374193)                         Forward                TGCTGCCCAGAACATCATCC
                                           Reverse                ACGGCAGGTCAGGTCAACAA

Statistical analysis {#sec2-4}
--------------------

Statistical significance (*p* \< 0.05, *p* \< 0.01, *p* \< 0.001) of apparent differences in gene expression after poly(I:C) treatment was assessed by ANOVA and Tukey's multiple comparison test (GraphPad Prism 5.01, San Diego, CA, USA).

RESULTS AND DISCUSSION {#sec3}
======================

Viability test of DF-1 cells in various concentrations of poly(I:C) {#sec3-1}
-------------------------------------------------------------------

In this study, poly(I:C) treatment with different doses from 0.1 µg/mL to 100 µg/mL for 24 h decreased the viability of DF-1 cells (chicken fibroblasts cell line) by 77.41%, 57.63%, 56.28%, 46.69%, 43.06%, 43.19%, 44.22%, 43.32%, 38.9%, 39.19%, 38.25%, 38.1%, 36.85%, 37.73%, 38.42%, 37.17%, and 38.68% respectively, compared to the non-treated control. The statistical analysis showed significant difference at all the treated concentrations except the concentration of 0.1 µg/mL, compared to the non-treated control and no difference among the cell viabilities from 0.5 µg/mL to 100 µg/mL poly(I:C) (*p* \< 0.05) ([Fig. 1](#F1){ref-type="fig"}). These results suggested that poly(I:C) rapidly affected on the cell viability from 0.5 µg/mL and this effect was saturated from 0.5 µg/mL to 100 µg/mL. Thus, we supposed that DF-1 cells could be much more sensitive to poly(I:C) than primary cultured CEFs.

![The viability and morphology of DF-1 cells in the poly(I:C)-treated conditions with various concentrations of poly(I:C) for 24 h.\
The statistical analysis was performed to assess statistical significance between each concentration and the non-treated control. Error bars were expressed as SEM ^\*^*p* \< 0.05, ^\*\*^*p* \< 0. 01, ^\*\*\*^*p* \< 0.001.](jast-62-3-385-g1){#F1}

Dose- and time-dependent expression patterns of TLRs by poly(I:C) treatment {#sec3-2}
---------------------------------------------------------------------------

TLR3 and TLR7 are known as NA-sensing TLRs while the function of TLR4 is associated with the recognition of endotoxins molecules, in particular lipopolysaccharide from gram-negative bacteria \[[@B13],[@B32]\]. Recently, the several studies have shown that TLR3, 4, and 7 mediated the responses to the viral-associated PAMPs such as poly(I:C), F protein of Respiratory Syncytial Virus (RSV), and imidazoquinolines, antiviral therapeutic compounds, respectively \[[@B33]--[@B38]\]. In addition, it has been reported that selective activation of TLR3/4-IRF3 pathway was associated with potential inhibition of viral replication \[[@B39]\]. *TLR15*, an avian-specific TLR, has been reported to be induced by salmonella, mycoplasma, and even Marek's Disease Virus (MDV) \[[@B16],[@B18],[@B19],[@B40]\]; however, the specifically virus-associated agonist was still unknown \[[@B41]\]. Instead of mammalian *TLR9* which was missing from the chicken genome, chicken TLR21 acted as a functional homologue to the mammalian TLR9 to recognize CpG \[[@B17]\]. Poly(I:C) and CpG ODN (CpG-motif containing oligodeoxydinucleotide) synergized the expression of pro-inflammatory cytokines and chemokines and the production of nitric oxide in chicken monocytes \[[@B42],[@B43]\].

To investigate chicken TLRs expressions in response to poly(I:C) treatment, the expressions of chicken TLRs were analyzed dose and time-dependently. From the analysis, the expressions of *TLR3*, *4, 7, 15*, and *21* were significantly induced at the poly(I:C) concentrations of 5 µg/mL and 10 µg/mL for 24 h ([Fig. 2A](#F2){ref-type="fig"}). In addition, the expression levels of *TLR3, 4, 7, 15*, and *21* were significantly increased with 10 µg/mL poly(I:C) at 12 h and 24 h after poly(I:C) treatment ([Fig. 2B](#F2){ref-type="fig"}). Therefore, we suggested that poly(I:C) was directly targeted at these TLRs in DF-1 cells to stimulate immune responses.

![Dose- and time-dependent expression patterns of TLRs by poly(I:C) treatment.\
The expressions of *TLR3, 4, 7, 15*, and *21* in DF-1 cells were analyzed in poly(I:C)-treated conditions with concentrations of 0, 0.1, 1, 5, and 10 µg/mL for 24 h (A) and with concentration of 10 µg/mL for 1, 3, 6, 12, and 24 h (B). The statistical analysis was performed to assess statistical significance between each treated condition and the non-treated control. Error bars were expressed as SEM ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, ^\*\*\*^*p* \< 0.001.](jast-62-3-385-g2){#F2}

Dose- and time-dependent expression patterns of TLR signaling-associated transcription factors (TFs) by poly(I:C) treatment {#sec3-3}
---------------------------------------------------------------------------------------------------------------------------

TLRs which recognize their ligands activated conserved TFs including AP-1, NF-κB, and IRFs through the interplay of complex TLR signaling pathways \[[@B44]--[@B47]\]. Among the AP-1 family, JUN that was a target protein of c-Jun N-terminal kinase (JNK) was regarded as a key factor in TLR signaling \[[@B47]\]. Among NF-κB protein complex, NF-κB1 (also known as p50) was known to have DNA binding activity for the promoter region of its target genes \[[@B48]\]. Among IRFs, IRF3 and IRF7 were activated by various ligands, such as poly(I:C), LPS, and virus infection and mainly controlled type-I IFN expression \[[@B49]\]. In mammalian, type I IFNs-mediated signaling pathways were dependent on the stimulus and the responding cell types. TLR signaling pathways associated with type I IFN, TLR3 and TLR4 induced type I IFN production in various cell types in a manner dependent on TIR-domain-containing adaptor protein inducing IFN*β* (TRIF) whereas TLR7, TLR8 and TLR9 induced type I IFN production in dendritic cells via a pathway dependent on MYD88. Eventually they can activate some common signaling molecules including TNF receptor-associated factor 3 (TRAF3) and IRF3 and IRF7 \[[@B49],[@B50]\]. Additionally, poly(I:C) treatment increased *IRF7* and *type-I IFN* (*IFNA*) in DF-1 cells \[[@B25]\].

To reveal TFs which are associated with TLR signaling responded to poly(I:C), the expressions of *IRF7*, *JUN*, and *NF-κB1* were analyzed in DF-1 cells at different doses of poly(I:C) and time points. From the dose-dependent treatment, *IRF7* and *NF-κB1* expressions were significantly increased at 5 µg/mL and 10 µg/mL and 5 µg/mL of the poly(I:C) treatment for 24 h, respectively. Whereas the expression of *JUN* was significantly decreased at 1 µg/mL, 5 µg/mL, and 10 µg/mL of poly(I:C) for 24 h ([Fig. 3A](#F3){ref-type="fig"}). When the expressions of *IRF7*, *JUN*, and *NF-κB1* were analyzed with 10 µg/mL poly(I:C) according to time course, the expression of *IRF7* steadily increased from 3 h to 24 h after poly(I:C) treatment. *JUN* and *NF-κB1* expressions were commonly increased from 1 h to 3 h after poly(I:C) treatment, but were decreased from 6 h to 24 h after poly(I:C) treatment ([Fig. 3B](#F3){ref-type="fig"}). These results suggested that *TLR3* stimulation by poly(I:C) induced *IRF7* transcription, whereas the expressions of *JUN* and *NF-κB1* were gradually decreased and maintained to the ground state although they were rapidly induced within 1 h after the poly(I:C) treatment. Thus, we speculated that poly(I:C) may mainly induce immune-effector genes by *IRF7*-mediated signaling pathway after the recognition by TLRs such as *TLR3, 4, 7, 15*, and *21* in 24 h after the treatment while direct or indirect pathways may exist to acutely induce *JUN* and *NF-κB1*. The further study is necessary to prove the activation of TLR pathway-mediated TFs.

![Dose- and time-dependent expression patterns of TLR signaling-associated transcription factors (TFs) by poly(I:C) treatment.\
The expressions of IRF7, JUN, and NF-κB1 in DF-1 cells were analyzed in poly(I:C)-treated conditions with concentrations of 0, 0.1, 1, 5, and 10 µg/mL for 24 h (A) and with concentration of 10 µg/mL for 1, 3, 6, 12, and 24 h (B). The statistical analysis was performed to assess statistical significance between each treated condition and the non-treated control. Error bars were expressed as SEM ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, ^\*\*\*^*p* \< 0.001.](jast-62-3-385-g3){#F3}

Dose- and time-dependent expression patterns of immune-related effector molecules by poly(I:C) treatment {#sec3-4}
--------------------------------------------------------------------------------------------------------

From TLRs recognizing their ligands, the activated TFs can induce a variety of interferons, cytokines and chemokines \[[@B9],[@B39]\]. During the immune responses, cytokine and chemokine families acted as extracellular molecular regulators which mediated immune cell recruitment and participated in complex intracellular signaling processes \[[@B9]\]. Among them, IL1B belonging to IL1 family and IL10 have been known as a pro-inflammatory and an anti-inflammatory cytokine respectively. These cytokines were induced by viral infections \[[@B9],[@B51]--[@B53]\]. IL8, a critical inflammatory chemokine was also upregulated by various viral infection in human epithelial cells \[[@B54]\].

To examine whether the expressions of immune-related effector genes are affected by poly(I:C) treatment, *IL1B*, *IL8L2* (*chicken IL8-like 2*), and *IL10* expressions were analyzed after the poly(I:C) treatment at different dose and time points. From the analysis, the expressions of *IL1B*,*IL8L2*, and *IL10* were significantly increased by poly(I:C) treatments from 5 µg/mL to 10 µg/mL for 24 h ([Fig. 4A](#F4){ref-type="fig"}). In time-dependent analysis, the expressions of *IL1B*, and *IL10* were significantly increased from 12 h to 24 h after the poly(I:C) treatment ([Fig. 4B](#F4){ref-type="fig"}). Unlike *IL1B* and *IL10*, the expression of *IL8L2* showed the rapid increase at 3 h after the poly(I:C) treatment and reached to the plateau at 6 h after the poly(I:C) treatment. In addition, it was continuously decreased from 12 h to 24 h after the poly(I:C) treatment compared to the expression of *IL8L2* at 6 h after the poly(I:C) treatment although the expressions of *IL8L2* at 12 h and 24 h after the poly(I:C) treatment were still higher than the non-treated control ([Fig. 4B](#F4){ref-type="fig"}). This result suggested that the inductions of *IL1B*,*IL8L2*, and *IL10* in DF-1 cells could be mediated by TLR-signaling pathways. In addition, *IL8L2* could more sensitively respond to poly(I:C) and be inhibited by other feedback systems compared to IL1B and IL10.

![Dose- and time-dependent expression patterns of immune-related effector molecules by poly(I:C) treatment.\
The expressions of IL1B, IL8L2, and IL10 in DF-1 cells were analyzed in poly(I:C)-treated conditions with concentrations of 0, 0.1, 1, 5, and 10 µg/mL for 24 h (A) and with concentration of 10 µg/mL for 1, 3, 6, 12, and 24 h (B). The statistical analysis was performed to assess statistical significance between each treated condition and the non-treated control. Error bars were expressed as SEM ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, ^\*\*\*^*p* \< 0.001.](jast-62-3-385-g4){#F4}

Conclusively, we suggested the distinct TLR signaling pathways which responded to poly(I:C) in chicken-originated cell line (DF-1) compared to mammalian TLRs for NA-sensing and their signaling pathways. Our results could contribute to understanding NA-sensing and subsequent immune signaling pathways in chicken cells.
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